Paclitaxel controversy to headline inaugural CX 2020 LIVE session
Join a wealth of experts and faculty from around the world for the very first session of CX 2020 LIVE—the inaugural virtual Charing Cross (CX) Symposium—titled ‘Paclitaxel-coated Device Consensus Update’.
Renowned interventional radiologist Andrew Holden (Auckland, New Zealand), who is a member of the CX Peripheral Arterial Executive Board, welcomes the medical community to the first session, which will focus on the latest updates in the ever-evolving paclitaxel story. The session will look to establish consensus on the safety of paclitaxel in the peripheral arteries.
CX 2020 LIVE will consist of 10 live sessions, which will feature audience participation, and run from 16:00 BST/11:00 EDT/17:00 CEST every Tuesday and Thursday, from 26 May until 25 June.